102 related articles for article (PubMed ID: 12742624)
1. Surface and intracellular nicotinic receptors expressed in intact adrenal chromaffin cells: direct measurements using [3H]epibatidine.
Free RB; McKay DB
Brain Res; 2003 Jun; 974(1-2):60-9. PubMed ID: 12742624
[TBL] [Abstract][Full Text] [Related]
2. Cotinine binding to nicotinic acetylcholine receptors in bovine chromaffin cell and rat brain membranes.
Vainio PJ; Tuominen RK
Nicotine Tob Res; 2001 May; 3(2):177-82. PubMed ID: 11403732
[TBL] [Abstract][Full Text] [Related]
3. [3H]Epibatidine binding to bovine adrenal medulla: evidence for alpha3beta4* nicotinic receptors.
Free RB; Bryant DL; McKay SB; Kaser DJ; McKay DB
Neurosci Lett; 2002 Jan; 318(2):98-102. PubMed ID: 11796195
[TBL] [Abstract][Full Text] [Related]
4. Characterization of [(3)H]epibatidine binding to nicotinic receptors from bovine adrenal medulla.
McKay DB; Free RB; Kaser DJ; McKay SB
Ann N Y Acad Sci; 2002 Oct; 971():162-4. PubMed ID: 12438112
[No Abstract] [Full Text] [Related]
5. Receptor protection studies comparing recombinant and native nicotinic receptors: Evidence for a subpopulation of mecamylamine-sensitive native alpha3beta4* nicotinic receptors.
Free RB; Kaser DJ; Boyd RT; McKay DB
Neurosci Lett; 2006 Jan; 392(1-2):135-9. PubMed ID: 16198480
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of nicotinic receptors of rat chromaffin cells by N,N, N-trimethyl-1-(4-trans-stilbenoxy)-2-propylammonium iodide: a patch clamp and ligand binding study.
Di Angelantonio S; Nistri A; Moretti M; Clementi F; Gotti C
Br J Pharmacol; 2000 Apr; 129(8):1771-9. PubMed ID: 10780985
[TBL] [Abstract][Full Text] [Related]
7. Agonist-induced up-regulation of alpha4beta2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition.
Whiteaker P; Sharples CG; Wonnacott S
Mol Pharmacol; 1998 May; 53(5):950-62. PubMed ID: 9584223
[TBL] [Abstract][Full Text] [Related]
8. High-affinity epibatidine binding of functional, human alpha7-nicotinic acetylcholine receptors stably and heterologously expressed de novo in human SH-EP1 cells.
Peng JH; Fryer JD; Hurst RS; Schroeder KM; George AA; Morrissy S; Groppi VE; Leonard SS; Lukas RJ
J Pharmacol Exp Ther; 2005 Apr; 313(1):24-35. PubMed ID: 15590768
[TBL] [Abstract][Full Text] [Related]
9. Evidence for spare nicotinic acetylcholine receptors and a beta 4 subunit in bovine adrenal chromaffin cells: studies using bromoacetylcholine, epibatidine, cytisine and mAb35.
Wenger BW; Bryant DL; Boyd RT; McKay DB
J Pharmacol Exp Ther; 1997 May; 281(2):905-13. PubMed ID: 9152400
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of recombinant bovine alpha3beta4 neuronal nicotinic receptors stably expressed in HEK 293 cells.
Free RB; von Fischer ND; Boyd RT; McKay DB
Neurosci Lett; 2003 Jun; 343(3):180-4. PubMed ID: 12770692
[TBL] [Abstract][Full Text] [Related]
11. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the functional subunit combination of nicotinic acetylcholine receptors in bovine adrenal chromaffin cells.
Tachikawa E; Mizuma K; Kudo K; Kashimoto T; Yamato S; Ohta S
Neurosci Lett; 2001 Oct; 312(3):161-4. PubMed ID: 11602335
[TBL] [Abstract][Full Text] [Related]
13. Expression of native alpha3beta4* neuronal nicotinic receptors: binding and functional studies investigating turnover of surface and intracellular receptor populations.
Free RB; McKay SB; Gottlieb PD; Boyd RT; McKay DB
Mol Pharmacol; 2005 Jun; 67(6):2040-8. PubMed ID: 15772292
[TBL] [Abstract][Full Text] [Related]
14. Substance P and epibatidine-evoked catecholamine release from fractionated chromaffin cells.
Krause W; Michael N; Lübke C; Livett BG; Oehme P
Eur J Pharmacol; 1997 Jun; 328(2-3):249-54. PubMed ID: 9218708
[TBL] [Abstract][Full Text] [Related]
15. Sigma-1 receptor ligands inhibit catecholamine secretion from adrenal chromaffin cells due to block of nicotinic acetylcholine receptors.
Brindley RL; Bauer MB; Hartley ND; Horning KJ; Currie KPM
J Neurochem; 2017 Oct; 143(2):171-182. PubMed ID: 28815595
[TBL] [Abstract][Full Text] [Related]
16. Gene targeting demonstrates that alpha4 nicotinic acetylcholine receptor subunits contribute to expression of diverse [3H]epibatidine binding sites and components of biphasic 86Rb+ efflux with high and low sensitivity to stimulation by acetylcholine.
Marks MJ; Meinerz NM; Drago J; Collins AC
Neuropharmacology; 2007 Sep; 53(3):390-405. PubMed ID: 17631923
[TBL] [Abstract][Full Text] [Related]
17. Expression of nicotinic acetylcholine receptors in human and rat adrenal medulla.
Mousavi M; Hellström-Lindahl E; Guan ZZ; Bednar I; Nordberg A
Life Sci; 2001 Dec; 70(5):577-90. PubMed ID: 11811902
[TBL] [Abstract][Full Text] [Related]
18. Enhanced antinociception by nicotinic receptor agonist epibatidine and adrenal medullary transplants in the spinal subarachnoid space.
Caban AJ; Hama AT; Lee JW; Sagen J
Neuropharmacology; 2004 Jul; 47(1):106-16. PubMed ID: 15165838
[TBL] [Abstract][Full Text] [Related]
19. Interaction of the catecholamine release-inhibitory peptide catestatin (human chromogranin A(352-372)) with the chromaffin cell surface and Torpedo electroplax: implications for nicotinic cholinergic antagonism.
Taupenot L; Mahata SK; Mahata M; Parmer RJ; O'Connor DT
Regul Pept; 2000 Nov; 95(1-3):9-17. PubMed ID: 11062327
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity studies with ring E analogues of methyllycaconitine on bovine adrenal alpha3beta4* nicotinic receptors.
Bryant DL; Free RB; Thomasy SM; Lapinsky DJ; Ismail KA; McKay SB; Bergmeier SC; McKay DB
Neurosci Res; 2002 Jan; 42(1):57-63. PubMed ID: 11814609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
